Miniatura

Fitxers

725907.pdf (3.84 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2022-08-05

Llicència de publicació

cc-by-nc-nd (c) Latorre J et al., 2022
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/192992

Downregulation of hepatic lipopolysaccharide binding protein improves lipogenesis-induced liver lipid accumulation

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1016/j.omtn.2022.08.003

Resum

Circulating lipopolysaccharide-binding protein (LBP) is increased in individuals with liver steatosis. We aimed to evaluate the possible impact of liver LBP downregulation using lipid nanoparticle-containing chemically modified LBP small interfering RNA (siRNA) (LNP-Lbp UNA-siRNA) on the development of fatty liver. Weekly LNP-Lbp UNA-siRNA was administered to mice fed a standard chow diet, a high-fat and high-sucrose diet, and a methionine- and choline-deficient diet (MCD). In mice fed a high-fat and high-sucrose diet, which displayed induced liver lipogenesis, LBP downregulation led to reduced liver lipid accumulation, lipogenesis (mainly stearoyl-coenzyme A desaturase 1 [Scd1]) and lipid peroxidation-associated oxidative stress markers. LNP-Lbp UNA-siRNA also resulted in significantly decreased blood glucose levels during an insulin tolerance test. In mice fed a standard chow diet or an MCD, in which liver lipogenesis was not induced or was inhibited (especially Scd1 mRNA), liver LBP downregulation did not impact on liver steatosis. The link between hepatocyte LBP and lipogenesis was further confirmed in palmitate-treated Hepa1-6 cells, in primary human hepatocytes, and in subjects with morbid obesity. Altogether, these data indicate that siRNA against liver Lbp mRNA constitutes a potential target therapy for obesity-associated fatty liver through the modulation of hepatic Scd1.

Matèries

Toxines bacterianes, Lípids, Obesitat

Matèries (anglès)

Citació

Col·leccions

Articles publicats en revistes (Bioquímica i Biomedicina Molecular)

Citació

LATORRE, Jessica, DÍAZ-TRELLES, Ramon, COMAS, Ferran, GAVALDÀ I NAVARRO, Aleix, MILBANK, Edward, DRAGANO, Nathalia, MORÓN-ROS, Samantha, MUKTHAVARAM, Rajesh, ORTEGA, Francisco, CASTELLS-NOBAU, Anna, OLIVERAS-CAÑELLAS, Núria, RICART, Wifredo, KARMALI, Priya p, TACHIKAWA, Kiyoshi, CHIVUKULA, Pad, VILLARROYA I GOMBAU, Francesc, LÓPEZ, Miguel, GIRALT I OMS, Marta, VILLARROYA I GOMBAU, Francesc, MORENO-NAVARRETE, José maría. Downregulation of hepatic lipopolysaccharide binding protein improves lipogenesis-induced liver lipid accumulation. _Molecular Therapy-Nucleic Acids_. 2022. Vol. 29, núm. 599, pàgs. 599-613. [consulta: 14 de gener de 2026]. ISSN: 2162-2531. [Disponible a: https://hdl.handle.net/2445/192992]

Exportar metadades

JSON - METS

Compartir registre